Startups
Investors Back Seattle-Based Startup’s Novel Immuno-Oncology Program Targeting Solid Tumors
2020-09-26
A German Biotech Company Developing Novel Precision Canonical Antibodies was Founded and Funded
2020-09-10
Building a Biomedical Value Chain and Accelerating the Development of the Biomedical Industry
2020-07-29Partner
BIO Asia–Taiwan 2020 Online + Live for the Opportunity to Share Your Company’s Achievements and Goals
2020-05-30Partner
Endometriosis Precision Detection Company, V-CHECK Eyes Global Market
2020-02-26Partner
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115